Metabolic and respiratory effects of theophylline in the preterm infant.
about
Apnea of prematurity: from cause to treatmentCurrent nutrition management of infants with chronic lung disease.Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.Cardiorespiratory events in preterm infants: etiology and monitoring technologies.Apneic preterms and methylxanthines: arousal deficits, sleep fragmentation and suppressed spontaneous movements.Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
P2860
Metabolic and respiratory effects of theophylline in the preterm infant.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Metabolic and respiratory effects of theophylline in the preterm infant.
@en
Metabolic and respiratory effects of theophylline in the preterm infant.
@nl
type
label
Metabolic and respiratory effects of theophylline in the preterm infant.
@en
Metabolic and respiratory effects of theophylline in the preterm infant.
@nl
prefLabel
Metabolic and respiratory effects of theophylline in the preterm infant.
@en
Metabolic and respiratory effects of theophylline in the preterm infant.
@nl
P2093
P2860
P356
P1476
Metabolic and respiratory effects of theophylline in the preterm infant.
@en
P2093
Carnielli VP
Cavedagni M
Filippone M
Zacchello F
P2860
P304
P356
10.1136/FN.83.1.F39
P577
2000-07-01T00:00:00Z